Our data showed that FOXP3+ expression was frequently observed in tumor and peri-tumoral compartments, suggesting that regulatory CD4+ lymphocytes had a greater tendency to infiltrate tumoral parenchyma. This evidence concerns the gene FOXP3 and neoplasm.